Copyright
©The Author(s) 2022.
World J Cardiol. Apr 26, 2022; 14(4): 190-205
Published online Apr 26, 2022. doi: 10.4330/wjc.v14.i4.190
Published online Apr 26, 2022. doi: 10.4330/wjc.v14.i4.190
Figure 4 COVID-19 related cardiac dysfunction on cardiac magnetic resonance imaging.
Cardiac magnetic resonance imaging of an adult woman with COVID-19-related perimyocarditis. A, B: Significantly raised native T1 and native T2 in myocardial mapping acquisitions; C, D: Pericardial effusion and enhancement (yellow arrowheads) and epicardial and intramyocardial enhancement (white arrowheads) using LGE acquisition. Modified from Puntmann et al[75] and licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).
- Citation: Nguyen Nguyen N, Assad JG, Femia G, Schuster A, Otton J, Nguyen TL. Role of cardiac magnetic resonance imaging in troponinemia syndromes. World J Cardiol 2022; 14(4): 190-205
- URL: https://www.wjgnet.com/1949-8462/full/v14/i4/190.htm
- DOI: https://dx.doi.org/10.4330/wjc.v14.i4.190